1
|
A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: isolation by panning and stimulation with vascular endothelial growth factor.
|
Exp Cell Res
|
1997
|
1.07
|
2
|
Identification and functional assessment of endothelial P1H12.
|
J Lab Clin Med
|
2001
|
0.96
|
3
|
PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells.
|
Br J Cancer
|
2010
|
0.85
|
4
|
Development of mycosis fungoides after bone marrow transplantation for chronic myeloid leukaemia: transmission from an allogeneic donor.
|
Br J Dermatol
|
2014
|
0.83
|
5
|
Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype.
|
Int J Lab Hematol
|
2012
|
0.80
|
6
|
Retinal and cerebral toxoplasmosis following nonmyeloablative stem cell transplant for chronic lymphocytic leukaemia.
|
Bone Marrow Transplant
|
2005
|
0.76
|
7
|
Coagulase-negative staphylococcal bacteraemia treated with teicoplanin.
|
J Antimicrob Chemother
|
1993
|
0.75
|
8
|
Successful outcome of patients with relapsed/refractor Hodgkin lymphoma treated with high dose chemotherapy at the National Adult Bone Marrow Transplant Unit at St. James's Hospital.
|
Ir Med J
|
2009
|
0.75
|
9
|
Weekly intermittent 2-CdA is less toxic and equally efficacious when compared to continuous infusion in hairy cell leukaemia.
|
Br J Haematol
|
1999
|
0.75
|
10
|
Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT.
|
Eur J Haematol
|
2004
|
0.75
|
11
|
Haemoglobin Etobicoke, an incidental finding in an Irish diabetic.
|
Clin Lab Haematol
|
2003
|
0.75
|
12
|
Use of DLI to achieve complete donor chimerism in a patient receiving systemic immunosuppression for refractory AIHA post-NST.
|
Bone Marrow Transplant
|
2005
|
0.75
|
13
|
Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).
|
Eur J Haematol Suppl
|
2001
|
0.75
|
14
|
Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003.
|
Ir J Med Sci
|
2005
|
0.75
|
15
|
Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
|
Eur J Haematol
|
2006
|
0.75
|